High intratumoural galectin-1 expression predicts adverse outcome in ALK(-) ALCL and CD30(+) PTCL-NOS

Holst, JM; Ludvigsen, M; Hamilton-Dutoit, SJ; Bendix, K; Plesner, TL; Norgaard, P; Moller, MB; Steiniche, T; Rabinovich, GA; d'Amore, F; Pedersen, MB

Holst, JM (corresponding author), Aarhus Univ Hosp, Dept Hematol, Palle Juul Jensens Blvd 35, DK-8200 Aarhus, Denmark.

HEMATOLOGICAL ONCOLOGY, 2020; 38 (1):

Abstract

Galectin-1 (Gal-1) has been associated with adverse prognosis in several cancers including lymphoma entities with CD30 expression. However, Gal-1 expr......

Full Text Link